Aurora Cannabis Acquires The Remaining ~90% Equity Interest In MedReleaf Australia At An Enterprise Value Of AUD$50M

  • Aurora becomes the largest global medical cannabis company operating in nationally legal markets.
  • MedReleaf Australia holds the #2 position in medical cannabis within the rapidly growing ~AUD$400 million1 Australian market.
  • Transaction is expected to be immediately accretive to Adjusted EBITDA2 and accelerate the Company's plan for Positive Free Cash Flow2 generation in calendar 2024.

Image
igniteit
February 8, 2024 • 11:55 am
Share: